From the Los Angeles Times
IN THE LAB
Safer than estrogen?
Researchers, in their quest for a hot-flash remedy, consider alternatives such as steroids and antidepressants.
By Chandra Shekhar
Special to The Times
July 23, 2007
VIVIAN AIZAWA of Salinas vividly remembers the first time her body was
hit by a heat wave out of the blue -- an episode of warmth, flushing
and sweating that "almost felt like climate change," the 53-year-old
says. The hot flashes and night sweats affected her sleep and strained
her relationships. "It is ruining my life," she told her doctor.
Nearly three out of four women will share Aizawa's experience as they
go through menopause. Many, in fact, will get hot flashes and night
sweats several times a day for years, each episode lasting from a few
seconds to several minutes.
FOR THE RECORD: Hot flashes: A July 23 Health article on
remedies for hot flashes said that a study led by Johns Hopkins
Medicine researchers found that women who have hot flashes could have
oversensitive serotonin receptors. The statement was a theory based on
rat studies —not a finding -- included in a review of hot flash studies
written by the Johns Hopkins researchers.
"It impacts literally millions of women worldwide," says Dr. Wulf
Utian, president of the Ohio-based North American Menopause Society, a
nonprofit that promotes menopause research. "While not
life-threatening, it is a major impediment to their quality of life."
For relief, women have tried dozens of remedies: herbs, low-fat diets,
antidepressants. Then, in 1942, came a major advance. The U.S. Food and
Drug Administration approved Premarin, a form of the female sex hormone
estrogen extracted from horse urine. Since then, extensive studies have
shown that the hormone, either alone or in combination with other sex
hormones, really works: It relieves moderate to severe symptoms in 90%
of women who take estrogen.
But hormone therapy does not suit all women; those with a family
history of early breast or ovarian cancer, for instance, probably have
to avoid it. And many others have concerns about long-term estrogen
use, especially in the years since the landmark Women's Health
Initiative trial, which reported a few years back that hormones
slightly raised the risk of not only breast cancer but also heart
attacks and strokes. (See "Hormones: Is age the key?")
Others are willing to take the hormone but suffer unpleasant side
effects such as breast tenderness and vaginal discharges. "For these
women, the cure is worse than the problem," says Dr. Nananda Col,
associate professor of medicine at Brown Medical School in Providence,
R.I.
And so researchers are looking for alternatives -- substances that can
calm sweats and flashes while presenting fewer risks. They have
identified some possible candidates -- drugs such as the antidepressant
venlafaxine, the steroid tibolone and the anticonvulsant gabapentin --
and trials are underway to evaluate some of them. At the same time,
scientists are gaining a better understanding of what actually causes
hot flashes.
In hot surroundings, humans cool their bodies in two ways: by sweating,
which dissipates heat by evaporation, or by flushing, which cools
heated blood by circulating it through dilated blood vessels in the
skin.
In hot-flash sufferers, both responses are often inappropriately
triggered by signals from the hypothalamus, the part of the brain that
regulates temperature. When this occurs, there is a discrepancy between
the woman's sensation of warmth and her actual body temperature.
Old studies using thermometers placed in the mouth, ear or rectum
failed to detect a temperature change during a hot flash. More recent
studies, using ingested thermometers, show that there is often a core
temperature change, but a small one: less than one-tenth of a degree
Fahrenheit. This increase precedes 60% of hot-flash episodes.
How this tiny thermal spike could trigger such an intense feeling of
warmth is less clear, though. Further, small temperature fluctuations
occur even in women who don't get hot flashes. Evidently, some women
tolerate body temperature fluctuations better than others.
To explain how this could be, Dr. Robert Freedman, professor of
psychiatry at Wayne State University School of Medicine in Detroit, has
devised the notion of a "thermoneutral zone," the range of body
temperatures a person endures comfortably. It's sandwiched between a
"sweating threshold," above which one feels too hot, and a "shivering
threshold," below which one feels too cold.
The size of this zone in younger, non-menopausal women is about one
degree, but in hot-flash sufferers it shrinks to almost zero, Freedman
has found. Even a minuscule spike in temperature pushes the body over
the sweating threshold, triggering a hot flash. "You've got no play in
the system in these women," Freedman says.
What causes this loss of heat tolerance is still a mystery. Earlier
researchers put the blame squarely on the loss of estrogen during
menopause, but now scientists think that the picture may be more
complex. For one thing, researchers have found no connection between a
hot-flash episode and the sufferer's estrogen level at that moment.
Also, there is no difference between estrogen levels of hot-flash
sufferers and other menopausal women.
Finally, although estrogen is nearly 90% effective in treating hot
flashes, it doesn't work for everyone. "Hormone deficiency is one
factor but not the whole deal," Freedman says.
In their search for a more direct cause -- and new remedies --
researchers have zeroed in on activity of the brain-signaling chemicals
norepinephrine and serotonin inside the hypothalamus. Freedman's
studies suggest that levels of norepinephrine are higher in women who
get hot flashes. Another study led by Johns Hopkins Medicine
researchers in Baltimore found that these women may also have
oversensitive serotonin receptors.
Either factor could reduce the body's ability to tolerate temperature variations , researchers say.
These changes might explain why venlafaxine, an antidepressant that
regulates brain levels of both chemicals, is about 60% effective in
reducing the frequency or severity of hot flashes. Medically classified
as a Serotonin-Norepinephrine Reuptake Inhibitor, or SNRI, venlafaxine
so far has been evaluated for hot flashes in small-scale and short-term
clinical trials; larger and longer-duration trials are now underway.
Studies show that other antidepressants such as fluoxetine (Prozac),
which regulates serotonin alone, are also effective, but somewhat less
so. "The SNRIs are a very promising avenue," says Dr. Andrea Rapkin,
professor of obstetrics and gynecology at UCLA and author of a recent
review paper on non-hormonal hot-flash therapies.
Another drug that appears to increase the body's tolerance of
temperature fluctuations is tibolone, a steroid that mimics the effects
of estrogen and other sex hormones. Available in Europe but not
approved by the FDA for use in the U.S., tibolone has been shown in
some small-scale studies to be effective in treating hot flashes. A
clinical trial of the drug in Mexico with 200 subjects is expected to
finish in 2008.
The anticonvulsant drug gabapentin is another potential treatment. A
2005 study found that the drug was effective at higher doses in
reducing the severity and frequency of hot flashes in women with breast
cancer.
But few experts believe that any of these non-estrogen remedies will
replace hormone therapy as the standard treatment for menopausal
symptoms. None of the drugs matches estrogen in effectiveness, and all
carry their own side effects.
Further, none of these drugs has yet been validated in trials that
match the vast scale, scope and duration of the estrogen studies.
Despite the slightly elevated risk of heart disease, stroke and breast
cancer, hormone therapy remains the best option for the majority of
recently menopausal women, says Dr. JoAnn Manson, professor of medicine
at Harvard Medical School in Boston and a lead investigator in the
Women's Health Initiative study. "It would be unfortunate for women
with distressing symptoms to avoid this treatment for fear of very rare
risks," she says.
For Aizawa, whose hot flashes often made her very irritable with her
husband and colleagues, the choice was clear: estrogen. "The well-being
of my life mattered more," she says.
*